AN ONGOING PHASE Ib TRIAL ASSESSING MOSUNETUZUMAB MONOTHERAPY AND COMBINED MOSUNETUZUMAB AND VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA | Publicación